Evidence map›Paper›PMID 33884888›Full record

ReviewJournal of the American Heart Association2021

Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization.

Ziad A Ali, Jennifer Horst, Prakriti Gaba, Leslee J Shaw, Sripal Bangalore, Judith S Hochman, David J Maron, Jeffrey W Moses, Maria A Alfonso, Mahesh V Madhavan and 3 more

Abstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Impact of Complete Revascularization in the ISCHEMIA Trial.Journal of the American College of Cardiology · 2023
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Indicators of abnormal PET coronary flow capacity in detecting cardiac ischemia.The international journal of cardiovascular imaging · 2023
    Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ziad A AliClinical Trials Center Cardiovascular Research Foundation New York NY.
Jennifer HorstClinical Trials Center Cardiovascular Research Foundation New York NY.
Prakriti GabaNew York-Presbyterian Hospital/Columbia University Irving Medical Center New York NY.
Leslee J ShawDepartment of Radiology NewYork-Presbyterian Hospital and Weill Cornell Medicine New York NY.
Sripal BangaloreNew York University Grossman School of Medicine New York NY.
Judith S HochmanNew York University Grossman School of Medicine New York NY.
David J MaronDepartment of Medicine Stanford University Stanford CA.
Jeffrey W MosesDeMatteis Cardiovascular Institute St. Francis Hospital Roslyn NY.
Maria A AlfonsoClinical Trials Center Cardiovascular Research Foundation New York NY.
Mahesh V MadhavanNew York-Presbyterian Hospital/Columbia University Irving Medical Center New York NY.
Ovidiu DresslerClinical Trials Center Cardiovascular Research Foundation New York NY.
Harmony ReynoldsNew York University Grossman School of Medicine New York NY.
Gregg W StoneClinical Trials Center Cardiovascular Research Foundation New York NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guideline-based medical therapy is the foundation of treatment for individuals with coronary artery disease. However, revascularization with either percutaneous coronary intervention or coronary artery bypass grafting may be beneficial in patients with acute coronary syndromes, refractory symptoms, or in other specific scenarios (eg, left main disease and heart failure). While the goal of percutaneous coronary intervention and coronary artery bypass grafting is to achieve complete revascularization, anatomical and ischemic definitions of complete revascularization and their methodology for assessment remain highly variable. Such lack of consensus invariably contributes to the absence of standardized approaches for invasive treatment of coronary artery disease. Herein, we propose a novel, comprehensive, yet pragmatic algorithm with both anatomical and ischemic parameters that aims to provide a systematic method to assess complete revascularization after percutaneous coronary intervention or coronary artery bypass grafting in both clinical practice and clinical trials.

Indexed as

Angioplasty, Balloon, CoronaryCoronary Artery BypassCoronary Artery DiseaseCoronary VesselsHumansPercutaneous Coronary Interventioncoronary artery bypasspercutaneous coronary interventionrevascularization

Identifiers

PMID33884888
PMCPMC8200725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.